New knife may speed up colon polyp removal
NCT ID NCT04919824
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a new bipolar knife to a standard monopolar knife for removing colon polyps using a procedure called endoscopic submucosal dissection (ESD). About 80 adults with colon growths will be randomly assigned to one knife. Researchers will measure how fast the procedure goes and check for complications like bleeding or pain. The goal is to see if the new knife is safer or more efficient.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- bipolar radiofrequency ablation knife
- What this could lead to
- If the bipolar knife works better, it could make colon polyp removal faster and reduce complications like bleeding or pain.
- What could go wrong
- This is a small, early-stage trial with only 80 people. The new knife may not be faster or safer than the standard one, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
80 people
The number who actually took part.
- Started
-
Jan 2022
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patient is ≥ 18 years old 2. Patient is capable of providing informed consent 3. Patient is referred for ESD procedure of gastrointestinal neoplastic lesions Exclusion Criteria: 1. Patient is \< 18 years old 2. Patient refused and/or unable to provide consent 3. Patient is a pregnant woman 4. Patients with lesions removed with other techniques besides ESD or a modified ESD technique (i.e., EMR or TEM) as defined in the Japan Gastroenterological Endoscopy Society (JGES) guidelines for endoscopic resection of lesions.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gastrointestinal neoplasms are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Baylor St. Lukes Medical Center (BSLMC)
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental drug velzatinib offered to GIST patients who have run out of options
- Muscle loss may predict who struggles after cancer surgery
- Radioactive antibody aims to light up hidden solid tumors
- Can a disposable device improve endoscopic tissue closure?
- New drug velzatinib tested for Hard-to-Treat stomach and intestinal tumors
- Can a digital Pre-Surgery boost help cancer patients recover faster?